Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
89%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (11.1%)
N/A8 (88.9%)

Trials by Status

completed556%
recruiting111%
unknown222%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9